Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Clinical Lung Cancer
|
April 3, 2017
An Open-Label, Randomized, Controlled Phase II Study of Paclitaxel-Carboplatin Chemotherapy With Necitumumab Versus Paclitaxel-Carboplatin Alone in First-Line Treatment of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer
David R Spigel, Alexander Luft, Henrik Depenbrock, et al.
Plos One
|
April 11, 2020
Lessons learned from using respondent-driven sampling (RDS) to assess sexual risk behaviors among Kenyan young adults living in urban slum settlements: A process evaluation
Larissa Jennings Mayo-Wilson, Muthoni Mathai, Grace Yi, et al.
Advanced Healthcare Materials
|
June 11, 2026
Forming a Precise and Reproducible Hypoxic Tumor Microenvironment in Glioblastoma by High Cell Density Bioprinting
Emmie Jie Yao, Grace Yi Lu, Raghavendra Vadla, et al.
European Child & Adolescent Psychiatry
|
September 4, 2020
Assessing trauma and related distress in refugee youth and their caregivers: should we be concerned about iatrogenic effects?
M Claire Greene, Jeremy C Kane, Paul Bolton, et al.
The Journal of Physiology
|
June 29, 2023
The astrocytic Na<sup>+</sup> -HCO<sub>3</sub> <sup>-</sup> cotransporter, NBCe1, is dispensable for respiratory chemosensitivity
Keyong Li, Elizabeth C Gonye, Ruth L Stornetta, et al.
Cancer Chemotherapy and Pharmacology
|
June 18, 2016
Evaluation of the effect of necitumumab on the corrected QT interval in patients with advanced solid tumors
David C Smith, John Powderly, James J Lee, et al.
The Lancet. Gastroenterology & Hepatology
|
May 18, 2020
Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre, open-label, single-arm, dose-escalation study
Guolan Lu, Nynke S van den Berg, Brock A Martin, et al.
Theranostics
|
June 23, 2021
EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial
Quan Zhou, Nynke S van den Berg, Eben L Rosenthal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 25, 2022
Factors for Differential Outcome Across Cancers in Clinical Molecule-Targeted Fluorescence Imaging
Quan Zhou, Nynke S van den Berg, Wenying Kang, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Clinical Lung Cancer
|
April 3, 2017
An Open-Label, Randomized, Controlled Phase II Study of Paclitaxel-Carboplatin Chemotherapy With Necitumumab Versus Paclitaxel-Carboplatin Alone in First-Line Treatment of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer
David R Spigel, Alexander Luft, Henrik Depenbrock, et al.
Plos One
|
April 11, 2020
Lessons learned from using respondent-driven sampling (RDS) to assess sexual risk behaviors among Kenyan young adults living in urban slum settlements: A process evaluation
Larissa Jennings Mayo-Wilson, Muthoni Mathai, Grace Yi, et al.
Advanced Healthcare Materials
|
June 11, 2026
Forming a Precise and Reproducible Hypoxic Tumor Microenvironment in Glioblastoma by High Cell Density Bioprinting
Emmie Jie Yao, Grace Yi Lu, Raghavendra Vadla, et al.
European Child & Adolescent Psychiatry
|
September 4, 2020
Assessing trauma and related distress in refugee youth and their caregivers: should we be concerned about iatrogenic effects?
M Claire Greene, Jeremy C Kane, Paul Bolton, et al.
The Journal of Physiology
|
June 29, 2023
The astrocytic Na<sup>+</sup> -HCO<sub>3</sub> <sup>-</sup> cotransporter, NBCe1, is dispensable for respiratory chemosensitivity
Keyong Li, Elizabeth C Gonye, Ruth L Stornetta, et al.
Cancer Chemotherapy and Pharmacology
|
June 18, 2016
Evaluation of the effect of necitumumab on the corrected QT interval in patients with advanced solid tumors
David C Smith, John Powderly, James J Lee, et al.
The Lancet. Gastroenterology & Hepatology
|
May 18, 2020
Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre, open-label, single-arm, dose-escalation study
Guolan Lu, Nynke S van den Berg, Brock A Martin, et al.
Theranostics
|
June 23, 2021
EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial
Quan Zhou, Nynke S van den Berg, Eben L Rosenthal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 25, 2022
Factors for Differential Outcome Across Cancers in Clinical Molecule-Targeted Fluorescence Imaging
Quan Zhou, Nynke S van den Berg, Wenying Kang, et al.
Page
of 5